JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

Targeting HER2 for localised oesophageal cancer

Lordick, Florian
Author Lordick, Florian Department of Medicine II and University Cancer Center Leipzig, University of Leipzig Medical Center, Leipzig 04103, Germany. Electronic address: florian.lordick@medizin.uni-leipzig.de
Obermannová, Radka
Author Obermannová, Radka Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic
Smyth, Elizabeth C
Author Smyth, Elizabeth C Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

The Lancet. Oncology. 2022 Feb ; 23 (2) : 188-190. [epub] 20220114

Lancet Oncol
ISSN 1474-5488 | 1470-2045
Source

Language English Country Great Britain, England Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't, Comment

Persistent link https://www.medvik.cz/link/pmid35038428

PubMed 35038428
DOI 10.1016/s1470-2045(22)00004-3
PII: S1470-2045(22)00004-3
Knihovny.cz E-resources

MeSH
Esophagogastric Junction MeSH
Humans MeSH
Esophageal Neoplasms * drug therapy genetics MeSH
Check Tag
Humans MeSH
Publication type
Journal Article MeSH
Comment MeSH
Research Support, Non-U.S. Gov't MeSH

Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute and Faculty of Medicine Masaryk University Brno Czech Republic

Department of Medicine 2 and University Cancer Center Leipzig University of Leipzig Medical Center Leipzig 04103 Germany

Department of Oncology Cambridge University Hospitals NHS Foundation Trust Cambridge UK

Comment On

Lancet Oncol. 2022 Feb;23(2):259-269. doi: 10.1016/S1470-2045(21)00718-X. PubMed

References provided by Crossref.org

Borrow
RIS

Find record

In BMC

Citation metrics